Biospecimens for Identification of Diseases of the Pancreas.
NCT01392027 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 712
Last updated 2017-11-08
Summary
This proposed project is designed to collect data and specimens from patients/subjects presenting to the University of Michigan with a disease affecting the pancreas (or specific control populations). This protocol is focused on collecting data, blood samples, and tissue on subjects with pancreatic diseases, including pancreatic cancer, pancreatic cysts, pancreatitis, diabetic controls, jaundice/biliary obstruction controls, and otherwise healthy controls.
We are collecting up to 50 mls of blood for research purposes only. Plasma, serum and buffy coat are collected and stored according to strict SOPs.
Conditions
- Pancreatic Cancer
- Chronic Pancreatitis
- Type II Diabetes
- Pancreatic Cysts
- Healthy Control
Interventions
- PROCEDURE
-
Blood Draw
Blood draw for research specimens only
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2017-08-31
- Completion
- 2017-08-31
Countries
- United States
Study Locations
More Related Trials
-
Cohort Study of Pancreatic Cancer Risk
NCT04247503 ·Status: ACTIVE_NOT_RECRUITING
-
Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer
NCT05400681 ·Status: UNKNOWN
-
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
NCT03855800 ·Status: RECRUITING ·Phase: NA
-
DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer
NCT02079363 ·Status: UNKNOWN
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
NCT03628651 ·Status: COMPLETED
-
Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection
NCT00584363 ·Status: COMPLETED
-
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
NCT01807325 ·Status: COMPLETED
-
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
NCT00900094 ·Status: COMPLETED
-
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
NCT06148298 ·Status: RECRUITING
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
NCT02474160 ·Status: RECRUITING
-
Collection of Biological Specimens and Associated Health Information
NCT06369441 ·Status: NOT_YET_RECRUITING
-
Metabolic Phenotypes in Melanoma
NCT05570227 ·Status: RECRUITING ·Phase: NA
-
Arizona Cancer Center Biospecimen Repository
NCT00896935 ·Status: RECRUITING
-
Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood
NCT06544083 ·Status: RECRUITING
-
Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples
NCT02239575 ·Status: WITHDRAWN
-
Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.
NCT03174574 ·Status: COMPLETED
-
Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients
NCT04316507 ·Status: UNKNOWN ·Phase: NA
-
Creation of the BioBank, Early Detection and Discovery Biomarkers
NCT00901680 ·Status: COMPLETED
-
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
NCT04406831 ·Status: RECRUITING
-
UNC Pleural Fluid Registry
NCT05620329 ·Status: RECRUITING
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
NCT01137643 ·Status: RECRUITING
-
Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies
NCT04764396 ·Status: TERMINATED ·Phase: NA
-
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT05181826 ·Status: RECRUITING